Safe Baby Formula Act of 2026
- Sponsor
- Rep. Barrett, Tom [R-MI-7]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Jul 27, 2026
Bottom line
The "Safe Baby Formula Act of 2026" aims to enhance infant safety by requiring a study on toxic metals in formula and establishing regulatory limits for their presence.
What it actually does
This bill mandates the Secretary of Health and Human Services to conduct a study on the health impacts of heavy metals like arsenic, cadmium, mercury, and lead in infant formula. Crucially, it also requires the Secretary to establish evidence-based action levels for these toxic metals in infant formula within 90 days of enactment, considering compliance feasibility, enforcement capacity for imports, and domestic food security.
Proponents argue
Supporters argue this bill is a critical step to protect the health and development of infants by directly addressing concerns about toxic heavy metals in a foundational food source. They contend that establishing clear, evidence-based action levels will provide much-needed regulatory clarity and ensure manufacturers produce safer products, reducing long-term health risks associated with early exposure to these contaminants.
Opponents contend
Opponents might argue that the timeline for establishing action levels (90 days) is overly aggressive, potentially leading to standards that are difficult for manufacturers to meet without significant cost increases or supply chain disruptions, which could impact domestic food security. They might also suggest that existing regulatory frameworks or industry self-regulation are sufficient, or that a more comprehensive study should precede immediate regulatory action.
The bill is very short and can be read and understood quickly, allowing ample time for informed evaluation.
Section 2
Mandate for Study on Toxic Metals in Infant Formula
This section requires the Secretary of Health and Human Services to conduct a study within one year of the bill's enactment. The study will investigate the health impacts of arsenic, cadmium, mercury, and lead when present in infant formula on infant health. This research is intended to provide a scientific basis for future regulatory actions.
Supporters argue
Supporters argue that a dedicated study is essential to fully understand the scope and severity of heavy metal contamination in infant formula and its specific effects on infant health, ensuring that subsequent regulations are robust and scientifically sound.
Critics contend
No specific opposition is typically raised against conducting studies on public health issues, though some might argue that immediate action is needed rather than further study, or that existing research is sufficient.
Tradeoffs
The tension lies between the desire for immediate regulatory action and the need for comprehensive scientific understanding to inform the most effective and feasible standards.
Section 3(a)
Establishment of Evidence-Based Action Levels
This provision mandates the Secretary of Health and Human Services to establish evidence-based action levels for arsenic, cadmium, mercury, and lead in infant formula within 90 days of the bill's enactment. These action levels will set maximum permissible concentrations for these toxic metals, effectively prohibiting their presence above certain thresholds.
Section 3(b)
Factors for Establishing Action Levels
When establishing the action levels, the Secretary of Health and Human Services is required to consider three key factors: the feasibility for manufacturers to comply with the new levels, the Department's ability to enforce these standards, especially for imported formula, and the potential impact of these levels on domestic food security, ensuring that essential products remain available.
This section defines "infant formula" by referencing Section 201(z) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(z)). This means the bill's scope is tied to an existing legal definition rather than creating a new one.
Section 4
Why it matters:This is standard legislative practice to ensure consistency with existing law and avoid redundancy.
Case for: Referencing existing definitions streamlines legislation and prevents conflicting interpretations across different statutes.
Case against: A reader unfamiliar with 21 U.S.C. 321(z) would need to look up the external definition to fully understand the scope of products covered by the bill.
Estimated impact: Ensures the bill applies to the specific category of products already regulated as infant formula under federal law, impacting the entire infant formula market.